Fri, February 21, 2020

Andrew Mok Maintained (AMED) at Hold with Increased Target to $208 on, Feb 21st, 2020

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-208-on-feb-21st-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Andrew Mok of UBS, Maintained "Amedisys, Inc." (AMED) at Hold with Increased Target from $154 to $208 on, Feb 21st, 2020.

Andrew has made no other calls on AMED in the last 4 months.



There are 5 other peers that have a rating on AMED. Out of the 5 peers that are also analyzing AMED, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Matt Borsch of "BMO Capital" Initiated at Hold and Held Target at $170 on, Friday, December 6th, 2019


These are the ratings of the 4 analyists that currently disagree with Andrew


  • John Ransom of "Raymond James" Maintained at Buy with Increased Target to $225 on, Thursday, February 20th, 2020
  • A.J. Rice of "Credit Suisse" Initiated at Buy and Held Target at $206 on, Friday, January 17th, 2020
  • Joanna Gajuk of "B of A Securities" Maintained at Strong Buy with Increased Target to $178 on, Tuesday, November 26th, 2019
  • Whit Mayo of "Baird" Upgraded from Hold to Buy on, Friday, November 1st, 2019